Charles R. Brown

Charles R. Brown

Auto-generated profile, based on publicly available information

Charles R. Brown

University of Tulsa

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2012 in Nature
Verified
Journal Article
Open access
PDF file
JMJakob von Moltke
Jakob von Moltke
NTNorver J. Trinidad
Norver J. Trinidad
MMMahtab Moayeri
Mahtab Moayeri
AKAlexander F. Kintzer
Alexander F. Kintzer
SWSamantha B. Wang
Samantha B. Wang
RVRussell E. Vance
Russell E. Vance
Induction of an eicosanoid storm is shown to be an unexpected consequence of inflammasome activation in peritoneal macrophages, leading to vascular leakage and rapid death in mice. Inflammasomes are multiprotein complexes that initiate early cellular responses to cellular pathogens. The mechanisms of inflammasome activation have been the focus of intense research, but relatively little is known about what pathways are activated downstream of inflammasomes. This study shows that systemic activation of the inflammasome in vivo results in the rapid induction of potent signalling lipids called eicosanoids, which cause a catastrophic loss of fluid from the blood, contributing to the death of the animal within 30 minutes. When restricted to the site of infection, eicosanoids may have a beneficial role in host defence, for example by increasing local vascular permeability, allowing an influx of immune cells. Detection of microbial products by host inflammasomes is an important mechanism of innate immune surveillance. Inflammasomes activate the caspase-1 (CASP1) protease, which processes the cytokines interleukin (IL)-1β and IL-18, and initiates a lytic host cell death called pyroptosis1. To identify novel CASP1 functions in vivo, we devised a strategy for cytosolic delivery of bacterial flagellin, a specific ligand for the NAIP5 (NLR family, apoptosis inhibitory protein 5)/NLRC4 (NLR family, CARD-domain-containing 4) inflammasome2,3,4. Here we show that systemic inflammasome activation by flagellin leads to a loss of vascular fluid into the intestine and peritoneal cavity, resulting in rapid (less than 30 min) death in mice. This unexpected response depends on the inflammasome components NAIP5, NLRC4 and CASP1, but is independent of the production of IL-1β or IL-18. Instead, inflammasome activation results, within minutes, in an ‘eicosanoid storm’—a pathological release of signalling lipids, including prostaglandins and leukotrienes, that rapidly initiate inflammation and vascular fluid loss. Mice deficient in cyclooxygenase-1, a critical enzyme in prostaglandin biosynthesis, are resistant to these rapid pathological effects of systemic inflammasome activation by either flagellin or anthrax lethal toxin. Inflammasome-dependent biosynthesis of eicosanoids is mediated by the activation of cytosolic phospholipase A2 in resident peritoneal macrophages, which are specifically primed for the production of eicosanoids by high expression of eicosanoid biosynthetic enzymes. Our results therefore identify eicosanoids as a previously unrecognized cell-type-specific signalling output of the inflammasome with marked physiological consequences in vivo.

1 January 1994 in Clinical Infectious Diseases
Verified
Journal Article
Closed access
PDF file
JMJames McAuley
James McAuley
KBKenneth M. Boyer
Kenneth M. Boyer
DPDushyant Patel
Dushyant Patel
MMMarilyn Mets
Marilyn Mets
CSCharles Swisher
Charles Swisher
RMRima McLeod
Rima McLeod
Between December 1981 and May 1991, 44 infants and children with congenital toxoplasmosis were referred to our study group. A uniform approach to evaluation and therapy was developed and is described herein along with the clinical characteristics of these infants and children. In addition, case histories that illustrate especially important clinical features or previously undescribed findings are presented. Factors that contributed to the more severe disabilities included delayed diagnosis and initiation of therapy; prolonged, concomitant neonatal hypoxia and hypoglycemia; profound visual impairment; and prolonged, uncorrected increased intracranial pressure with hydrocephalus and compression of the brain. Years after therapy was discontinued, three children developed new retinal lesions (without loss of visual acuity when therapy for Toxoplasma gondii was initiated promptly), and three children experienced a new onset of afebrile seizures. Most remarkable were the normal developmental, neurological, and ophthalmologic findings at the early follow-up evaluations of many—but not all—of the treated children despite severe manifestations, such as substantial systemic disease, hydrocephalus, microcephalus, multiple intracranial calcifications, and extensive macular destruction detected at birth. These favorable outcomes contrast markedly with outcomes reported previously for children with congenital toxoplasmosis who were untreated or treated for only 1 month.

15 December 2010 in The Journal of Infectious Diseases
Verified
Journal Article
Closed access
FBFengwei Bai
Fengwei Bai
KKKok‐Fai Kong
Kok‐Fai Kong
JDJianfeng Dai
Jianfeng Dai
FQFeng Qian
Feng Qian
LZLin Zhang
Lin Zhang
RMRuth R Montgomery
Ruth R Montgomery
Polymorphonuclear leukocytes (PMNs) are key in innate immunity, but their role in viral pathogenesis is incompletely understood. In infection due to West Nile virus (WNV), we found that expression of 2 PMN-attracting chemokines, Cxcl1 and Cxcl2, was rapidly and dramatically elevated in macrophages. PMNs are rapidly recruited to the site of WNV infection in mice and support efficient replication of WNV. Mice depleted of PMNs after WNV inoculation developed higher viremia and experienced earlier death, compared with the control group, which suggest a protective role for PMNs. In contrast, when PMNs were depleted prior to infection with WNV, and in mice deficient in Cxcr2 (a chemokine receptor gene), viremia was reduced and survival was enhanced. Collectively, these data suggest that PMNs have a biphasic response to WNV infection, serving as a reservoir for replication and dissemination in early infection and later contributing to viral clearance.

15 November 1990 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
CBC R Brown
C R Brown
RMR McLeod
R McLeod
To determine roles of MHC class I and II genes in protection against Toxoplasma gondii, H-2 congenic and mutant mice were infected perorally with bradyzoites of T. gondii and brain cysts were enumerated 30 days later. As B10 mice (H-2b) are cyst susceptible and B10.A mice (H-2a) are cyst resistant, B10 congenic mice having the same alleles but different H-2 haplotypes were used to locate the controlling gene. Genes located at H-2L (i.e., class I genes) were found to regulate the number of brain cysts which form following peroral infection with T. gondii (p less than 0.001) with Ld being resistant and Lb being susceptible. The regulatory function of the H-2L gene product was confirmed through the study of D mutant (dm) mice. B10.D2-H-2dm1 (dm1) mice have a gain-loss mutation in Dd and Ld (i.e., recombination of Ld and Dd) and BALB/c-H-2dm2 (dm2) mice have a deletion of the Ld gene. Both these dm strains were cyst susceptible (p less than 0.001). These results provide the first direct evidence that class I genes regulate numbers of T. gondii cysts that form. In vivo ablation of CD8+ T cells with mAb YTS 169.4 converted cyst resistant B10.BAR12 mice to cyst susceptible. This result is consistent with a role for MHC restricted CD8+ cytotoxic (or suppressor) T cell regulation of cyst formation. A mutation in Ia in B6.C-H-2bm12 (bm12) mice amplified cyst numbers in susceptible mice, which is consistent with the importance of helper/inducer T cells in the induction of cytotoxic T cells. These findings are relevant to understanding the complex immunologic mechanisms that protect against T. gondii infection, development of protective preparations, and provide a conceptual basis for determining whether similar immunogenetic regulation of susceptibility is also operative in humans.

1 October 1998 in Evolution
Verified
Journal Article
Closed access
PDF file
CBCharles R. Brown
Charles R. Brown
MBMary Bomberger Brown
Mary Bomberger Brown

20 April 2000 in Behavioral Ecology and Sociobiology
Verified
Journal Article
Closed access
PDF file
CBC. R. Brown
C. R. Brown
MBMary Bomberger Brown
Mary Bomberger Brown